Fig. 1: The clinical significance of FAAH and GPX4 in advanced ccRCC. | Cell Death & Disease

Fig. 1: The clinical significance of FAAH and GPX4 in advanced ccRCC.

From: Combination treatment with FAAH inhibitors/URB597 and ferroptosis inducers significantly decreases the growth and metastasis of renal cell carcinoma cells via the PI3K-AKT signaling pathway

Fig. 1

Quantitative polymerase chain reaction was used to detect the expression of FAAH and GPX4 in clinical specimens from ccRCC patients. (A, B) Patients were divided into two groups (high-expression group or low-expression group) according to their median expression of GPX4 (A) and FAAH (B). The results are displayed as scatter plots and histograms. Clinical analysis was performed based on follow-up data from patients (C, D). The prognosis of patients (overall survival) in the high/low groups of GPX4 (C) or high/low groups of FAAH (D) is shown as a survival curve. *P < 0.05.

Back to article page